Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous t-cell lymphoma and chronic graft-versus-host-disease patients

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 2, 2009, Pages 353-362

  Quaglino, Pietro ^a   Comessatti, A ^a   Ponti, R ^a   Peroni, A ^a   Mola, F ^a   Fierro, M T ^a   Savoia, P ^a   Novelli, M ^a   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cutaneous T cell lymphoma; Extracorporeal photochemotherapy; Flow cytometry; Graft versus host disease; T regulatory cells

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHOXSALEN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CD4+ CD25+ T LYMPHOCYTE; CHRONIC DISEASE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; EXTRACORPOREAL PHOTOCHEMOTHERAPY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; MALE; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SEZARY SYNDROME; T LYMPHOCYTE SUBPOPULATION; TREATMENT RESPONSE;

EID: 67650498506     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200212     Document Type: Article

References (34)

1. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987; 316:297-303.
2. Trautinger F, Knobler R, Willemze R, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur J Cancer 2006; 42:1014-1030
3. Knobler R, Jantschitsch C. Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma. Transfus Apher Sci 2003; 28:81-89 (Pubitemid 36298594)
4. Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S: Photopheresis Expert Group. UK consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol 2008; 158:659-78.
5. Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107:3074-3080 (Pubitemid 43034110)
6. Marques MB, Tuncer HH. Photopheresis in solid organ transplant rejection. J Clin Apher 2006; 21:72-77
7. Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann NY Acad Sci 2001; 941:1-11. (Pubitemid 32928328)
8. Fimiani M, Di Renzo M, Rubegni P. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol 2004; 150:1055-1060 (Pubitemid 38932273)
9. Bladon J, Taylor PC. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 2006; 43:85-94. (Pubitemid 44094006)
10. Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004; 114:1198-1208 (Pubitemid 40385287)
11. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Regulatory T cells and human disease. Clin Dev Immunol 2007; 2007:891-895
12. Tang Q, Bluestone JA. The FoxP3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9:239-244 (Pubitemid 351267321)
13. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D, Schwarz T. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174:5968-5976 (Pubitemid 40663783)
14. Lamioni A, Parisi F, Isacchi G, et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 79:846-850 (Pubitemid 40546206)
15. Gatza E, Rogers CE, Clouthier SG, Lowler KP, Tawara I, Liu C, Reddy P, Ferrara JL. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008; 112:1515-1521
16. Biagi E, Di Biaso I, Leoni V, et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+C D62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84:31-39 (Pubitemid 47094638)
17. Rubegni P, Sbano P, Cevenini G, et al. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy. Int J Immunopathol Pharmacol 2007; 20:801-807
18. Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, Fietta AM. Peripheral CD4(+)CD25(+) Treg cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39:213-217 (Pubitemid 46175985)
19. Lamioni A, Carsetti R, Legato A, Landolfo A, Isacchi G, Emma F, Bottazzo GF, Dello Strologo L. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007; 83:1393-1396 (Pubitemid 46800319)
20. Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 2005; 105:1640-1647 (Pubitemid 40223685)
21. Hallermann C, Niermann C, Schultze HJ. Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides. Eur J Immunol 2007; 78:260-263 (Pubitemid 46246527)
22. Capriotti E, Vonderheid EC, Thoburn CJ, Wasik MA, Bahler DW, Hess AD. Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. Leuk Lymphoma 2008; 49:1190-1201
23. Klemke CD, Fritzsching B, Franz B, et al. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas. Leukemia 2006; 20:1123-1129 (Pubitemid 43797307)
24. Gjerdrum LM, Woetmann A, Odum N, Burton CM, Rossen K, Skovgaard GL, Ryder LP, Ralfkiaer E. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 2007; 21:2512-2518 (Pubitemid 350148895)
25. Tiemessen MM, Mitchell TJ, Hendry L, Whittaker SJ, Taams LS, John S. Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma. J Invest Dermatol 2006; 126:2217-2223 (Pubitemid 44413168)
26. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-3785
27. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46:95-106. (Pubitemid 34073484)
28. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713-1722 (Pubitemid 47443880)
29. Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P, Cappello N, Fierro MT. The relevance of the CD4+CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001; 144:125-135. (Pubitemid 32154603)
30. Stevens SR, Ke MS, Parry EJ, Mark J, Cooper KD. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT). Arch Dermatol 2002; 138:42-48 (Pubitemid 34056233)
31. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-1253
32. highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 2006; 177:4488-4494 (Pubitemid 44469779)
33. Walsh PT, Benoit BM, Wysocka M, Dalton NM, Turka LA, Rook AH. A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4+CD25+Foxp3+ T-cell phenotype associated with HTLV-1 infection. J Invest Dermatol 2006; 126:690-692 (Pubitemid 43255661)
34. Möttönen M, Heikkinen J, Mustonen L, Isomäki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140:360-367 (Pubitemid 40559165)